Hepatitis B surface antigen detection using pooled sera. A cost-benefit analysis;Detección de HBsAg usando mezcla de sueros. Estudio coste-beneficio

Revista Espanola de Enfermedades Digestivas

Volumn 98, Issue 2, 2006, Pages 112-121

  Fernandez E ^a   Rodrigo, Luis ^b   Garcia S ^a   Riestra, S ^b   Blanco, C ^a  

^a HOSPITAL DE CABUEÑES   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Cost benefit analysis; Hepatitis B surface antigen; Pooling sera

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; PREVALENCE; SCREENING; SEROLOGY; BLOOD; BLOOD SAMPLING; ECONOMICS; HEPATITIS B; HETEROZYGOTE; MASS SCREENING; METHODOLOGY; SENSITIVITY AND SPECIFICITY; SPAIN;

BLOOD SPECIMEN COLLECTION; CARRIER STATE; COST-BENEFIT ANALYSIS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; MASS SCREENING; SENSITIVITY AND SPECIFICITY; SPAIN;

EID: 33646822645     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082006000200006     Document Type: Article

References (29)

1. Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990; 8 (Supl.): 18s-20s.
2. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Sem Liver Dis 1991; 11: 84-92.
3. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994; 23: 437-55.
4. Suárez A, Riestra S, Navascués CA, et al. Positive HBsAg blood donors in Asturias (Spain): current prevalence and its significance. (Engl abstract). Med Clin (Barcelona) 1994; 102: 329-32.
5. Emmanuel JC, Basset MT, Smith HJ, Jacobs JA. Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries. J Clin Pathol 1988; 41: 582-5.
6. Kline RL, Brothers TA, Brookmeyer R, et al. Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. J Clin Microbiol 1989; 27: 1449-52.
7. Cahoon-Young B, Chandler A, Livermore T, et al. Sensitivity and specificity of pooled versus individual sera in a human immunodeficiency virus antibody prevalence study. J Clin Microbiol 1989; 27: 1893-5.
8. Frosner GG, Dobler G, von Sonnenburg FJ. Cost reduction of unlinked testing for anti-HIV by investigation of pooled sera. AIDS 1990; 4: 73-5.
9. Behets F, Bertozzi S, Kasali M, et al. Sucessful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of costefficiency models. AIDS 1990; 4: 737-41.
10. Monzon OT, Paladin FJ, Dimaandal E, et al. Relevance of antibody content and test format in HIV testing of pooled sera. AIDS 1992; 6: 43-8.
11. Tamashiro H, Maskill W, Emmanuel J, et al. Reducing the cost of HIV antibody testing. Lancet 1993; 342: 87-90.
12. Perriens JH, Magazani K, Kapila N, et al. Use of a rapid test and an ELISA for HIV antibody screening of pooled serum samples in Lubumbashi, Zaire. J Virol Methods 1993; 41: 213-21.
13. McMahon EJ, Fang C, Layug L, Sandler SG. Pooling blood donor samples to reduce the cost of HIV-1 antibody testing. Vox Sang 1995; 68: 215-9.
14. Verstraeten T, Farah B, Duchateau L, Matu R. Pooling sera to reduce the cost of HIV surveillance: a feasibility study in a rural Kenyan district. Trop Med Int Health 1998; 3: 747-50.
15. Kamel MA, Ghaffar YA, Wasef MA, et al. High HCV prevalence in Egyptian blood donors. Lancet 1992; 340: 427.
16. Neil AGS, Conradie JD. Low cost anti-HCV screening of blood donors. Lancet 1992; 340: 1096.
17. Fernández E, Riestra S, García S, Rodríguez S. Pool tests for detection of hepatitis C virus infection. J Hepatol 1995; 23: 236.
18. García Z, Taylor L, Ruano A, et al. Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development. J Med Virol 1996; 49: 218-22.
19. Liu P, Shi ZX, Zhang YC, et al. A prospective study of a serum-pooling strategy in screening blood donors for antibody to hepatitis C virus. Transfusion 1997; 37: 732-6.
20. Cunningham R, Northwood JL, Kelly CD, et al. Routine antenatal screening for hepatitis B using pooled sera: validation and review of 10 years experience. J Clin Pathol 1998; 51: 392-5.
21. Rabenau H, Schutz R, Berger A, et al. How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus? (Engl abstract). Infus Transfus 1996; 23: 124-30.
22. Echevarría JE, León P, López JA, et al. HBsAg subtype distribution among different populations of HBsAg carriers in Spain. Eur J Epidemiol 1995; 11: 39-45.
23. Neill AGS, Conradie JD. Pool tests for hepatitis C virus. Lancet 1994; 343: 738.
24. Liu P, Shi ZX, Zhang YC, Zhang XY. Comparative study on 4 EIA kits for screening antibody to hepatitis C virus in pooled sera. Biomed Environ Sci 1998; 11: 75-80.
25. Recommendations for testing for HIV antibody on serum pool. WHO Weekly Epidemiol Rec 1991; 44: 316-27.
26. Lefrere JJ, Coste J, Defer C, et al. Screening blood donations for viral genomes: multicenter study of real-time simulation using pooled samples on the model of hepatitis C virus RNA detection. Transfusion 1998; 38: 915-23.
27. Yerly S, Pedrocchi M, Perrin L. The use of polymerase chain reaction in plasma pools for the concomitant detection of hepatitis C virus and HIV type 1 RNA. Transfusion 1998; 38: 908-14.
28. Schottstedt V, Tuma W, Bunger G, Lefevre H. PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service. Biologicals 1998; 26: 101-4.
29. Morandi PA, Schockmel GA, Yerly S, et al. Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2. J Clin Microbiol 1998; 36: 1534-8.